The Valley Desk

NCT04428151 · Interventional trial

Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009)

Overall registry status Terminated

Phase 2

Conditions Squamous Cell Carcinoma of Head and Neck

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov